Objectives: Patients receiving outpatient parenteral antimicrobial therapy (OPAT) may require emergency department (ED) visits to manage complications. This study's purpose was to identify risk factors for ED visits during OPAT and risk factors for hospitalization among patients with ED visits.
Introduction
Outpatient parenteral antimicrobial therapy (OPAT) has become a widely accepted form of therapy for patients who require intravenous antimicrobial therapy at home or other outpatient setting and it is estimated to be provided to 1 out of 1000 Americans every year. 1 It has allowed for shorter hospitalizations, resulting in lower costs of healthcare. 1, 2 The initial model of OPAT was the visiting nurse model, where parenteral antimicrobials were infused in patients' homes by visiting nurses. Over the years, many other models have been developed including the infusion centre model and the teach-and-train model. 3 The visiting nurse model in the USA has evolved into primarily a self-administration model with periodic (typically once weekly) visiting nurse support. The goal of all these models is to allow safe administration of parenteral antimicrobials outside an inpatient hospital setting.
Not every OPAT course concludes uneventfully. Unanticipated events that require attention include treatment failure, antimicrobial adverse events and vascular access complications. Some of these events lead to hospital admission. Previous hospitalization in the preceding 12 months, history of malignant lymphoma, longer planned OPAT duration, higher age, history of drug-resistant organisms, aminoglycoside use and lack of a primary care doctor have been identified as risk factors for hospital admission during OPAT. 4, 5 OPAT duration, female sex and injection drug use have been identified as risk factors for vascular access complications. 6 Some patients on OPAT develop a need to visit an emergency department (ED). Such visits are unanticipated and unwelcome events and constitute utilization of an expensive component of the healthcare system. ED visits during OPAT have not received as much attention as hospitalizations. In one study that examined ED visits for patients on OPAT at a tertiary care centre in Canada, 43% of 104 patients discharged home on OPAT visited an ED within 60 days. 7 An excess of ED visits stresses the healthcare system.
Elucidation of the frequency of ED visits during OPAT will help quantify the magnitude of this stress. Identification of risk factors that result in ED visits may help identify opportunities for preventing them. No prior study has comprehensively examined demographic and clinical characteristics of OPAT and their association with ED visits. The purpose of this study was to describe ED visits during OPAT, to identify risk factors for ED visits and to identify risk factors for hospitalization among patients who visit the ED.
Patients and methods

Study design and setting
The study was a retrospective cohort study conducted at Cleveland Clinic, a large multispecialty tertiary care referral centre in the USA. The Cleveland Clinic Health System (CCHS) includes the Cleveland Clinic Main Campus (a 1400 bed hospital), 10 regional hospitals in north-east Ohio and over 150 outpatient locations in northern Ohio, including 18 full-service family health centres and 21 express and urgent care sites. The entire health system uses a common electronic medical record (EMR), allowing for examination of patient care data throughout the system. Cleveland Clinic Main Campus has a large OPAT programme that has been in existence since 1979 and now encompasses 2500 OPAT courses a year. Initiation of OPAT at Cleveland Clinic requires evaluation by a Cleveland Clinic infectious disease attending physician. 8 An electronic structured start-of-care form is completed by the infectious disease physician at the start of the OPAT course. The Cleveland Clinic OPAT registry identifies patients through the OPAT start-of-care forms. The common EMR allows for identification of ED visits not just to Cleveland Clinic Main Campus but to the entire CCHS.
Screening, inclusion and exclusion criteria
All OPAT courses for patients aged .18 years started between 1 January 2013 and 1 January 2017 at Cleveland Clinic Main Campus were identified from the Cleveland Clinic OPAT registry and screened for inclusion in this study. The first OPAT course per patient during the study period was included. OPAT courses that lasted ,1 day were excluded.
Data sources and data extraction
Sources of data were the Cleveland Clinic OPAT registry and the Cleveland Clinic enterprise data vault (EDV). The Cleveland Clinic OPAT registry was used to identify OPAT episodes within the designated time frame, as well as the site of infection, antimicrobials, vascular access device, OPAT initiation date, the OPAT delivery site and planned duration of therapy. The comorbid conditions, residence ZIP code, county, health insurance and prior ED visits were obtained from the EDV. For the included patients, ED visits within the CCHS that occurred after the OPAT start date were searched for in the EDV and those that occurred within 30 days were identified. The reason for ED visit and patient disposition after the ED visit were ascertained by manual review of the EMR. For the sake of consistency, this was done by a single investigator. Study data were collected in a relational database (Microsoft V R Access).
Ethics
The study was approved by the Cleveland Clinic institutional review board (IRB no. . A waiver of the requirement for patient consent was granted.
Definitions
Age was defined as patient age on the OPAT start date. Comorbid conditions included diabetes mellitus, end-stage renal disease (on haemodialysis), COPD, liver cirrhosis and malignancy. Malignancy was defined as a history of haematological malignancy or solid tumour. The OPAT initiation site was 'inpatient' if the OPAT was begun during hospitalization and 'outpatient' if it was started in the outpatient setting. The OPAT delivery site could be home, residential facility or non-residential facility. Skilled nursing facilities and long-term acute care facilities were considered residential facilities. Infusion centres and dialysis centres were considered non-residential facilities. The county of residence was grouped into one of the following: Cuyahoga (county where Cleveland Clinic Main Campus is located), surrounding (county that has a border with Cuyahoga County), distant (a US county that does not border Cuyahoga County) and foreign (outside the USA). Medicare and Medicaid were considered government insurance. The mean annual household income for the year 2015 for the ZIP code in which the patient resided was taken to be the estimated patient income; it was calculated from publicly available data obtained from the Internal Revenue Service website. 9 ED visits resulting from the infectious disease being treated, antimicrobial adverse events or vascular access problems were categorized as OPAT-related ED visits.
Outcomes
The primary outcome was days to ED visit. Death and hospital admission were recognized as competing outcomes that would preclude an ED visit. An ED visit that led to hospital admission was counted as an ED visit.
Statistical analysis
Baseline characteristics of OPAT courses with or without at least one ED visit were compared. Continuous variables were compared using Student's t-test and categorical variables using the v 2 test. A frequency distribution of the reason for ED visit was tabulated.
Risk factors for ED visits were identified in a multivariable Cox proportional hazards regression model by examining the association of relevant demographic and clinical factors, which were felt to possibly influence need for an ED visit, with the first ED visit per patient. The outcome examined was time to ED visit. The time-to-event variable was censored at 30 days. For patients who died or were subsequently hospitalized within 30 days, before they had a single ED visit, the variable was censored on the date of death or the date of hospitalization, respectively. Explanatory variables included in the initial model were patient age (decade of age), gender, calendar year, OPAT initiation site, OPAT delivery site, county of residence, insurance (government, private, international, uninsured), income quartile, diagnoses being treated with OPAT, parenteral antimicrobials administered, log anticipated OPAT duration and prior ED visit within the previous year. Variable selection was then done by backward stepwise elimination of the variable that caused the greatest reduction in the Akaike Information Criterion (AIC) at each step until the optimal model was obtained, using the stepAIC function in the R package MASS. 10 Outliers were investigated for errors by examining case deletion residuals. The distribution of martingale residuals across values or levels of variables included in the final model was checked and the residuals were found to be evenly distributed. The proportional hazards assumption was checked using Schoenfeld residuals and the model was not in violation. To account for the competing risks of subsequent hospitalization or death, a subdistribution proportional hazards competing risks regression model was developed, with the variables in the final Cox proportional hazards model as the covariates, using the method of Fine and Gray. 11, 12 For the first ED visit per patient, for patients who did not have an intervening hospitalization, factors associated with hospital admission were examined in a multivariable logistic regression model including all the baseline variables as covariates. Variable selection was then done by backward stepwise selection to identify the optimal model based on identifying the model with the highest R 2 for each given number of predictors and the model with the lowest AIC among these models. 10 The final model was Emergency department visits during OPAT JAC checked for multicollinearity using generalized variance inflation factors 13, 14 and there was no evidence of it. The final model was checked for interaction effects and none was found.
Statistical analyses were done using R 15 using the core functions in the base package and the packages tableone, 16 survival, 17 MASS, 10 cmprsk 12 and car. 14 
Results
Between 1 January 2013 and 1 January 2017, 8263 patients were treated with a total of 11 391 OPAT courses. Of the 8263 OPAT courses included in the study (first OPAT course per patient), 416 (5%) had at least one ED visit within 30 days of initiation of OPAT, the first ED visit occurring a median of 10 days from the OPAT start date. Thirty-five had an intervening hospitalization between the OPAT start date and the first subsequent ED visit. Thus, 381 patients had at least one ED visit without an intervening hospitalization.
Baseline characteristics of included patients
The mean age at OPAT was 59 years (SD 16 years), 4737 (57%) were male and the median anticipated duration of OPAT was 20 days (IQR 11-34 days). The characteristics of the included patients are outlined in Table 1 .
Deaths, hospital admissions and ED visits
Three hundred and eighty-one patients (4.6%) had at least one ED visit within 30 days of OPAT initiation in the absence of an intervening hospitalization. In addition, 50 patients (0.6%) died and 1133 (14%) were hospitalized within 30 days without an intervening ED visit. The latter were patients who were admitted to hospital directly, not through the ED. The cumulative probabilities of having these competing events (ED visit, hospital admission and death) over time are shown in Figure 1 .
Description of ED visits
Of the 381 ED visits (first ED visit for patients who had at least one ED visit without an intervening hospitalization), 193 (51%) were OPAT related. The most common visit reason was vascular access complication, which accounted for 104 ED visits (54% of OPATrelated ED visits, 27% of all ED visits). The most common vascular access complications were occlusion and dislodgement, which accounted for 53 and 19 ED visits, respectively. The proportion of OPAT courses with at least one ED visit were 9.1%, 3.8%, 2.3% and 2.4%, respectively, for the years 2013, 2014, 2015 and 2016. Reasons for ED visit are outlined in Table 2 .
Risk factors for ED visits
Death and hospital admission were recognized as competing outcomes for ED visit and this was accounted for in the analysis. In a multivariable subdistribution proportional hazards competing risks regression model, the variables that were significantly associated with having an ED visit are shown in Table 3 . Notably, patients with a prior ED visit within the preceding year had a 2. ) and treatment with a parenteral penicillin (HR 1.31, 95% CI 1.06-1.61, P " 0.014). Factors associated with a significantly lower hazard of ED visits were higher age (HR 0.89 per decade of age, 95% CI 0.83-0.95, P " 4.0 % 10 #4 ), distant county as opposed to Cuyahoga County (HR 0.42, 95% CI 0.31-0.56, P " 8.5 % 10
#9
) and private insurance as opposed to government insurance (HR 0.59, 95% CI 0.46-0.77, P " 6.3 % 10
#5
). The hazard for ED visit was lower for each subsequent year compared with the year 2013.
Factors associated with hospital admission for patients who had ED visits
Among the 381 ED visits, 85 (22%) resulted in hospital admission. The factors that were independently associated with hospital admission are outlined in Table 4 . Among patients who visited the ED within 30 days of starting OPAT, patients on treatment with a parenteral antiviral agent had 33-fold higher odds of being admitted than patients not on parenteral antiviral agents (OR 33.37, 95% CI 3.98-384.71, P " 0.002). Compared with patients who visited the ED for non-OPAT-related reasons, those presenting with worsening infection had 19-fold higher odds (OR 18.95, 95% CI 5.50-79.85, P " 1.2 % 10
#7
) and those presenting with vascular access problems had 3-fold lower odds (OR 0.36, 95% CI 0.14-0.83, P " 0.022) of being admitted to hospital. The decision to admit to hospital from the ED was also influenced significantly by which ED the patient presented to.
Discussion
This study finds that, excluding patients who were admitted directly to hospital without passing through the ED, about 5% of patients on OPAT have at least one ED visit within the 30 days following initiation of OPAT. Patients with an ED visit within the previous year have a 2.3-fold higher hazard of having an ED visit than patients without an ED visit in the preceding year. This is probably partly a marker of access to care. Some patients have no other recourse than to visit an ED when faced with a medical problem that requires attention. It is also possible that some patients with repeated ED visits are those who have medical conditions that lead to more medical emergencies. About half of the ED visits are for non-OPAT-related reasons. This is a reflection of the underlying comorbidity burden in many patients who develop a condition that requires parenteral antimicrobial therapy. The study also shows that the decision to admit to hospital from the ED varies significantly by the reason for the ED visit. Patients visiting the ED for vascular access problems are much less likely to be admitted to hospital than patients visiting for worsening infection or non-OPAT-related reasons. This is probably because vascular access problems that bring patients to the ED can usually be addressed without having to admit the patient to the hospital.
The proportion of patients with an ED visit in our study (5% within 30 days) is much lower than was noted in a former study in Canada (43% within 60 days). 7 This difference can be explained by the difference in the study setting and the fact that duration of follow-up in the Canadian study was twice as long. The Canadian study was done in a centre without a formal OPAT programme Shrestha et al. and only half of the patients had an infectious disease referral. Our study was done in an institution with a well-organized OPAT programme where every patient is seen by an infectious disease physician. A notable finding in our study is a drop in the proportion of patients with ED visits from 9% in 2013 to 2.4% in 2015 and 2016. One of the factors that might have contributed to this decline was an initiative taken by the most frequently used home healthcare provider to manage catheter occlusions by Emergency department visits during OPAT JAC administering recombinant tissue plasminogen activator in patients' homes instead of sending them to the ED, a practice that was also soon adopted by other agencies. But this alone would not be an adequate explanation for this reduction. It is very likely that concomitant efforts by the institution to reduce hospital readmissions (a response to the introduction of financial penalties for 30 day readmissions by government payors) also inadvertently resulted in reduction of ED visits.
The biggest strength of this study is the large sample size. It allowed for use of more comprehensive models including many relevant variables that would not have been possible with a smaller study sample. Our OPAT programme and OPAT registry allowed for an accurate identification of all OPAT courses within our hospital. 8 Including all ED visits across the health system allowed for a more comprehensive picture of the ED visit burden than would have been possible if we had only examined ED visits in our own hospital. In a rapidly changing healthcare environment, incentives to visit or avoid the ED change with time and could influence the results of any study examining ED visits. To control for this factor we included calendar year as a covariate in our models, thereby adjusting for policy or process factors that might have changed over time.
The study has its limitations. We were only able to identify ED visits within the CCHS. There were certainly ED visits that occurred outside the CCHS, particularly for patients who lived at great distances from Cleveland Clinic. Cleveland Clinic Hospital is located in Cuyahoga County and all the EDs of the CCHS are located in Cuyahoga County or the surrounding counties. To control for the likelihood of visiting one of the EDs within the CCHS, we adjusted for the patients' county of residence in our models to account for the fact that patients who lived closer to the hospitals of the CCHS were more likely to visit one of the EDs associated with the CCHS. We also recognized that an important reason for patients to visit the ED is if they have no other place to seek care when they have a medical problem. Access to healthcare is determined by many socioeconomic factors including having health insurance, income, occupation, hours or shifts worked, transportation, number and age of dependents and the patients' social network. There is no standardized metric to measure access to healthcare. We attempted to control for healthcare access by adjusting for the COPD (P " 0.27), outpatient initiation (P " 0.27) and log anticipated OPAT duration (P " 0.45) were also included as variables in the final model but were not statistically significant. Prior ED visit within the preceding year. 
#7
a Age (P " 0.06), diabetes mellitus (P " 0.10) and OPAT site (P " 0.06) were also included as variables in the final model but were not statistically significant. b Lakewood (P " 0.38), Lutheran (P " 0.29) and other EDs (P " 0.29) not significant. c Institution teaching status (T " teaching and NT " non-teaching) and distance from Cleveland Clinic Main Campus. d Antimicrobial adverse event (P " 0.49) and symptoms associated with OPAT diagnosis (P " 0.16) not significant.
Shrestha et al.
patients' age, insurance and estimated annual income in our models. The study identifies previous ED visits within the preceding year as a risk factor for ED visits within 30 days of OPAT initiation. Regardless of the underlying reasons driving ED visits, patients with a prior ED visit within the preceding year constitute an easily identifiable group that can be targeted for intervention designed to reduce ED visits during OPAT. Occlusion is the most common vascular access problem resulting in ED visits. The knowledge that ED visits for vascular access complications are much less likely to result in hospitalization than ED visits for worsening infection or non-OPAT-related reasons reinforces the strategy of managing occlusions at the site of outpatient care.
In conclusion, about 5% of patients on OPAT have an ED visit within 30 days of initiation of OPAT. Compared with patients without, those with a prior ED visit within the preceding year have a 2.3-fold higher hazard of an ED visit. Only about half of the ED visits are for OPAT-related concerns, primarily vascular access problems. Patients who visit the ED for worsening infection are much more likely to be hospitalized than those who visit for vascular access complications.
